The funds have been infused in two tranches — Rs 2,175 crore in September and Rs 2,900 crore this month, totalling Rs 5,075 crore, according to financial data sourced through business intelligence platform Tofler. The reason behind the fund infusion in the Indian subsidiary is not known, but it is likely to be used for settling outstanding payments with dealers and vendors, and providing separation packages to employees.from Stocks-Markets-Economic Times
Read The Rest:economictimes...
